Christopher Cera

Christopher Cera serves as the Chief Commercial Officer at Adjacent Health, focusing on the development and execution of the company's commercial strategy and spearheading new product initiatives alongside the CEO and senior leadership. Prior to this role, Christopher operated Cera Consulting LLC, offering innovative commercialization strategies for early-stage neuro start-ups. Christopher has extensive experience in sales leadership, notably as Vice President of New Account Acquisition at Ceribell, where a national sales team was established to implement Ceribell's SaaS AI platform across 500 hospitals. Previous positions include various roles at CR Bard, Medivance®, and AccessClosure, culminating in a strong track record in sales growth and market development in the medical device industry. Christopher holds a Bachelor's degree in English with a minor in Communications from Susquehanna University.